BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30099761)

  • 1. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
    Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.
    Lee E; Song MJ; Lee HA; Kang SH; Kim M; Yang EK; Lee do Y; Ro S; Cho JM; Kim I
    Korean J Physiol Pharmacol; 2016 Sep; 20(5):477-85. PubMed ID: 27610034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.
    Bae EH; Kim IJ; Song JH; Choi HS; Kim CS; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
    Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
    Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
    Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
    Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
    Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
    Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells.
    Liu YW; Wang SA; Hsu TY; Chen TA; Chang WC; Hung JJ
    J Cell Biochem; 2010 Aug; 110(6):1430-8. PubMed ID: 20506344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
    Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
    Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
    J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of C/EBPβ-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis.
    Huang E; Huang H; Guan T; Liu C; Qu D; Xu Y; Yang J; Yan L; Xiong Y; Liang T; Wang Q; Chen L
    Toxicol Lett; 2019 Sep; 312():11-21. PubMed ID: 31059759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.
    Yoon GE; Jung JK; Lee YH; Jang BC; In Kim J
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):491-500. PubMed ID: 31655853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors restore normal hippocampal synaptic plasticity and seizure threshold in a mouse model of Tuberous Sclerosis Complex.
    Basu T; O'Riordan KJ; Schoenike BA; Khan NN; Wallace EP; Rodriguez G; Maganti RK; Roopra A
    Sci Rep; 2019 Mar; 9(1):5266. PubMed ID: 30918308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
    Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
    Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
    Iyer A; Fenning A; Lim J; Le GT; Reid RC; Halili MA; Fairlie DP; Brown L
    Br J Pharmacol; 2010 Apr; 159(7):1408-17. PubMed ID: 20180942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
    Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
    Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
    J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
    Raghunathan S; Goyal RK; Patel BM
    Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibitor trichostatin A suppresses osteoclastogenesis by upregulating the expression of C/EBP-β and MKP-1.
    Williams PJ; Nishu K; Rahman MM
    Ann N Y Acad Sci; 2011 Dec; 1240(1):18-25. PubMed ID: 22172035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.